David E. Kleiner
National Institutes of Health(US)National Cancer Institute(US)New York University(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease and Transplantation, Drug-Induced Hepatotoxicity and Protection
Most-Cited Works
- → Design and validation of a histological scoring system for nonalcoholic fatty liver disease†(2005)10,531 cited
- → Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis(2010)3,254 cited
- → MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease(2020)3,178 cited
- → Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease(2015)2,900 cited
- → Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma(2017)2,504 cited
- → Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial(2014)2,162 cited